Zuranolone approval for post-natal depression
Zuranolone approval for post-natal depression Zuranolone has been approved for treatment of postnatal depression in the USA. The Food and Drug Administration (FDA) approved a once daily oral medication for a fortnight. It allegedly showed marked improvement in depressive symptoms within three days and was maintained for tour weeks after the last dose. However the …